Renowned computational biologist Janet Thornton discusses the potential of protein structure understanding in developing new ...

It started as a respiratory illness—or so everyone thought. But it quickly became apparent that SARS-CoV-2, the virus that ...

The video shows two segments: one featuring commentary about a substance binding to the coronavirus surface, followed by a narration discussing vaccine spike protein structure and antibody responses.

The video shows two segments: one featuring commentary about a substance binding to the coronavirus surface, followed by a narration discussing vaccine spike protein structure and antibody responses.

This has enabled them to predict and characterize the interactions between variants of the SARS-CoV-2 spike protein, the virus responsible for Covid-19, and the human receptor hACE2. These advanced ...

Five years after SARS-CoV-2 first surfaced in Wuhan, China, researchers are still trying to understand long COVID. In this ...

The second possibility is that Covid has now settled into a rut, which will see it become progressively milder until it ultimately becomes akin to the common cold. Chin-Hong says that this would make ...

Newly developed vaccine could protect against emerging SARS-CoV-2 variants and related coronaviruses that may jump from ...

An image that is spreading widely online claims that Moderna had created its COVID-19 vaccine two years before the pandemic ...

On the eve of Donald Trump's inauguration, the US Department of Health banned the financing and activities of the EcoHealth ...

The study explores the potential of chitosan derivatives as novel inhibitors against the wild-type and emerging variants of ...

Chitosan, a naturally occurring polysaccharide derived from chitin, has demonstrated significant potential as an antiviral ...